|
Neisseria Meningitidis
Meningococcal
Infections: The Ongoing Saga
Chemoprophylaxis for
Health Care Workers Exposed to N. meningitidis
by
Trish M. Perl, MD, MSc
Rationale:
1.3 to 5.8% secondary cases result from exposure to a N.
meningitidis case
the
attack rate in persons exposed to a case with close contact (i.e.
household) is 500 to 800 times that of the general population
up to 85% of persons with close contact carry N.
meningitidis in their oropharynx after exposure to a case whereas
5-11% of persons living in crowded conditions carry N.
meningitidis in the oropharynx.
In general, hospital personnel have the same risk of developing
disease as the general population unless they have contact with
respiratory secretions. However, disease in health care workers is rare and thought to be
in part due to patient isolation and treatment that decrease the
chance of becoming a carrier.
A
prophylactic agent must
be safe
eliminate carriage rapidly and
for a prolonged period
achieve bactericidal concentrations
in saliva and tears
cost effective
limit change of antimicrobial
resistance
In
the health care setting, an agent also should be
practical (to assure compliance)
Review
of the literature: see attached sheet
Sulfonamides are no longer used because of wide spread drug resistance.
References:
Pusley,
Dworzack, Horowitz et al.. Efficacy of Ciprofloxacin in the treatment
of nasopharyngeal carriers of N. Meningitidis JID 1987:211-213.
Pusley,
Dworzack, Roccaforte et al.. An Open study of the efficacy of a
single dose of Ciprofloxacin in eliminating the chronic nasopharyngeal
carriage of N. Meningitidis
JID 1988 157:852-3.
Gutter,
Beaty. Minocycline in the chemoprophylaxis of meningococcal
disease. AAC 1972397-402
Gaunt,
Lambert. Single dose of Ciprofloxacin for the eradication
of pharynceal carriage of N.
Meningitidis. J Antimicrob
Chemother 1988 21:489-96.
Judson,
Ehret. Single dose ceftriaxone to eradicate pharyngeal N.
Meningitidis Lancet
1984.22/29:1462-3.
Devine,
Johnson, Hagerman etal. The effect of minocycline on meningococcal
nasopharyngeal carrier state in naval personnel. Am J Epidemiol 1971;93:337-45
| |
Efficacy
|
Side Effects
|
Resistance
|
Dose
|
Cost
|
Comments
|
|
Rifampin
|
75-90%
|
colored secretions
efficacy of BCP
25%side effects
|
10%
|
300 BID
2 days
|
$11.58
|
Red book & CDC recommendation contraindicated
in pregnancy
|
|
Ceftriaxone
|
97%
|
pain at injection
|
none reported
|
250 mg
|
$7.76
|
Use in pregnancy
|
|
Ciprofloxacin
|
93%
|
none reported
|
not reported
|
500 mg
|
$3.24
|
> 16 yrs
contraindicated in pregnancy
eradicates 75% of chronic carriers
|
|
Minocycline
|
84%
|
33% vertigo
|
67%
|
200mg load
100 BID X 5d
|
$68.40
|
experience in outbreaks
|
Top
of page
|